Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …

G protein-coupled receptors (GPCRs), comprising the largest superfamily of cell surface
receptors, serve as fundamental modulators of cardiac health and disease owing to their key …

Carvedilol, a β-blocker prescribed for chronic heart failure, suffers from poor bioavailability
and rapid first pass metabolism when administered orally. Herein, we present the …

Coronary artery disease (CAD) covers a wide spectrum from persons who are asymptomatic
to those presenting with acute coronary syndromes (ACS) and sudden cardiac death …

Despite the slowly progressive nature of NAFLD, the number of patients with NAFLD-related
cirrhosis significantly increased. Although the management of patients with cirrhosis …

Heart failure remains a leading cause of morbidity and mortality worldwide. Current
treatment for patients with heart failure include drugs targeting G protein‐coupled receptors …

In dilated cardiomyopathy (DCM), where the heart muscle becomes stretched and thin, heart
failure (HF) occurs, and the cardiomyocytes suffer from an energetic inefficiency caused by …

The article explores possibilities and consequences of the integration of artificial intelligence
(AI)-powered ChatGPT chatbot in geriatric medicine. It discusses the usage of ChatGPT for …

Abstract Purpose of Review Describe disparities in diagnosis and management between
men and women with advanced heart failure (HF). Our goal is to identify barriers and …

Background: Heart failure is associated with aging. It is one of the leading causes of
morbidity and mortality in Western countries and constitutes the main cause of …